Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2003The Journal of Urology

5α-Reductase Type 1 Immunostaining is Enhanced in Some Prostate Cancers Compared With Benign Prostatic Hyperplasia Epithelium

View Full Paper
Ask AI
Bookmark
Share

Authors

LTLynn N. ThomasDalhousie UniversityRDR.C. DouglasJVJohn P. VesseyUniversity of Guelph

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thomas et al. (2003) studied this question.

synapsesocial.com/papers/6a8afd6bf19228bbb2fb42d5https://doi.org/10.1097/01.ju.0000091804.20183.81
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Kinetic Parameters of 5α-Reductase Activity in Stroma and Epithelium of Normal, Hyperplastic, and Carcinomatous Human Prostates*1988 · 102 citations
  2. 2Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.1992 · 307 citations
  3. 3The proliferative function of basal cells in the normal and hyperplastic human prostate1994 · 252 citations
  4. 45 alpha-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro.1996 · 34 citations
  5. 5SELECTIVITY OF FINASTERIDE AS AN IN VIVO INHIBITOR OF 5 alpha-REDUCTASE ISOZYME ENZYMATIC ACTIVITY IN THE HUMAN PROSTATE1999 · 82 citations